pharmaphorum Podcast

For episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet the head of the company’s UK specialty business Kavya Gopal.

In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.

Prior to his current role Manfred spent 25 years at GlaxoSmithKline, most recently serving as president of GSK’s European consumer healthcare business, so he brought a truly informed perspective to the interview.

Manfred Scheske

He talked to Dominic Tyer about what it’s like for a small, up and coming healthcare company competing with big pharma and how his firm is seeking to bring innovation to the consumer realm.

With Infirst’s pharmacy-only Flarin having launched in the UK in January, Manfred talked about its development, clinical trial programme and how the lipid formulation of ibuprofen makes good on the firm’s ‘known drugs, made better’ mantra.

You can listen to episode 2 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the series – in iTunes.

In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.

Prior to his current role Manfred spent 25 years at GlaxoSmithKline, most recently serving as president of GSK’s European consumer healthcare business, so he brought a truly informed perspective to the interview.

Manfred Scheske

He talked to Dominic Tyer about what it’s like for a small, up and coming healthcare company competing with big pharma and how his firm is seeking to bring innovation to the consumer realm.

With Infirst’s pharmacy-only Flarin having launched in the UK in January, Manfred talked about its development, clinical trial programme and how the lipid formulation of ibuprofen makes good on the firm’s ‘known drugs, made better’ mantra.

You can listen to episode 2 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the series – in iTunes.

In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how he’s seen the consumer health sector develop.

Available to download now – the very first pharmaphorum podcast.

An interview with David Mitchell, Patients For Affordable Drugs

Our inaugural podcast ties in with the theme of pharmaphorum’s latest Deep Dive publication, which focuses on patients and patient centricity.

In it, pharmaphorum speaks to David Mitchell, President of Patients For Affordable Drugs. As its name suggests, Patients For Affordable Drugs is focused on just one subject – the high cost of prescription medicines in the US. In the last few years this has become an inescapable controversy in America, which has the highest drugs prices in the world.

There is a growing backlash against prescription medicine prices in the US, but patient groups have tended to avoid confronting pharma.

This has changed with Patients for Affordable Drugs, with its founder David Mitchell harnessing the anger of patients at the industry’s pricing strategies – and his own inside knowledge of Washington lobbying and of cancer treatment –  to bring about change in the US system.

Download the podcast now to hear what Mitchell has to say about industry-funded patient advocacy groups, President Trump and ex-big pharma health secretary Alex Azar.